Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Christopher Farnsworth and Ann Gronowski.
Christopher Farnsworth
Connection Strength
1.695
Ann Gronowski
  1. In Reply: Correctly Interpreting SARS-CoV-2 Serologic Assays. Clin Chem. 2020 09 01; 66(9):1245-1247.
    View in: PubMed
    Score: 0.901
  2. Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays. Clin Chem. 2020 12 01; 66(12):1538-1547.
    View in: PubMed
    Score: 0.229
  3. Clinical Performance of Two SARS-CoV-2 Serologic Assays. Clin Chem. 2020 08 01; 66(8):1055-1062.
    View in: PubMed
    Score: 0.224
  4. Clinical Performance of the Roche SARS-CoV-2 Serologic Assay. Clin Chem. 2020 08 01; 66(8):1107-1109.
    View in: PubMed
    Score: 0.224
  5. Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021. mSphere. 2021 08 25; 6(4):e0045021.
    View in: PubMed
    Score: 0.060
  6. Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA. mSphere. 2021 02 03; 6(1).
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.